Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 1
1978 2
1983 1
1984 1
1986 3
1987 1
1990 1
1991 1
1992 1
1994 3
1995 2
1996 2
1997 1
1998 2
2000 3
2001 4
2002 3
2003 4
2004 2
2005 9
2006 4
2007 6
2008 10
2009 7
2010 8
2011 13
2012 15
2013 24
2014 24
2015 22
2016 26
2017 25
2018 25
2019 29
2020 31
2021 26
2022 28
2023 24
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac sarcoidosis: diagnosis and management.
Markatis E, Afthinos A, Antonakis E, Papanikolaou IC. Markatis E, et al. Rev Cardiovasc Med. 2020 Sep 30;21(3):321-338. doi: 10.31083/j.rcm.2020.03.102. Rev Cardiovasc Med. 2020. PMID: 33070538 Free article. Review.
Despite this progress, isolated cardiac sarcoidosis is difficult to differentiate from other causes of arrhythmogenic cardiomyopathy. ...In this article current trends in the pathophysiology, diagnosis and management of cardiac sarcoidosis will be revi …
Despite this progress, isolated cardiac sarcoidosis is difficult to differentiate from other causes of arrhythmogenic cardiomy …
Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.
Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, Baughman R, Fayad ZA, Judson MA. Trivieri MG, et al. J Am Coll Cardiol. 2020 Oct 20;76(16):1878-1901. doi: 10.1016/j.jacc.2020.08.042. J Am Coll Cardiol. 2020. PMID: 33059834 Free PMC article. Review.
Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect virtually any organ. Although the lung is typically the most common organ involved, combined pulmonary and cardiac sarcoidosis (CS) account for most of the morbidity an …
Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect virtually any organ. Although the lung is …
Cardiac Sarcoidosis.
Mankad P, Mitchell B, Birnie D, Kron J. Mankad P, et al. Curr Cardiol Rep. 2019 Nov 25;21(12):152. doi: 10.1007/s11886-019-1238-1. Curr Cardiol Rep. 2019. PMID: 31768666 Free PMC article. Review.
RECENT FINDINGS: Academic interest in cardiac sarcoidosis research has increased over the past decade along with increased clinical awareness among clinicians. ...Two large multicenter prospective registries-the international Cardiac Sarcoidosis …
RECENT FINDINGS: Academic interest in cardiac sarcoidosis research has increased over the past decade along with increased …
Cardiac Sarcoidosis.
Tan JL, Fong HK, Birati EY, Han Y. Tan JL, et al. Am J Cardiol. 2019 Feb 1;123(3):513-522. doi: 10.1016/j.amjcard.2018.10.021. Epub 2018 Nov 6. Am J Cardiol. 2019. PMID: 30503798 Review.
Clinical and subclinical cardiac sarcoidosis (CS) remains diagnostically challenging as the sensitivity and specificity of the diagnostic modalities are limited. ...However, they are mostly based on expert opinions and lack clinical trial valida …
Clinical and subclinical cardiac sarcoidosis (CS) remains diagnostically challenging as the sensitivity and specificity …
Advanced sarcoidosis.
Baughman RP, Wells A. Baughman RP, et al. Curr Opin Pulm Med. 2019 Sep;25(5):497-504. doi: 10.1097/MCP.0000000000000612. Curr Opin Pulm Med. 2019. PMID: 31365384 Review.
Two large retrospective reviews demonstrated the effectiveness of infliximab in treating advanced neurosarcoidosis. Advanced cardiac sarcoidosis can lead to mortality. SUMMARY: Advanced sarcoidosis is associated with significant morbidity and some mortality. ...
Two large retrospective reviews demonstrated the effectiveness of infliximab in treating advanced neurosarcoidosis. Advanced cardiac …
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version.
Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI, Yamashina A; Japanese Circulation Society Joint Working Group. Terasaki F, et al. Circ J. 2019 Oct 25;83(11):2329-2388. doi: 10.1253/circj.CJ-19-0508. Epub 2019 Oct 9. Circ J. 2019. PMID: 31597819 Free article. No abstract available.
Current treatment of sarcoidosis.
Sellarés J, Francesqui J, Llabres M, Hernandez-Gonzalez F, Baughman RP. Sellarés J, et al. Curr Opin Pulm Med. 2020 Sep;26(5):591-597. doi: 10.1097/MCP.0000000000000720. Curr Opin Pulm Med. 2020. PMID: 32701680 Review.
Finally, new evidence has been published in the use of antitumor necrosis factor (anti-TNFalpha) agents in refractory cardiac sarcoidosis and neurosarcoidosis. SUMMARY: Sarcoidosis therapy is constantly evolving, and new drugs have been added to the recommended trea …
Finally, new evidence has been published in the use of antitumor necrosis factor (anti-TNFalpha) agents in refractory cardiac sarc …
Cardiac sarcoidosis.
Mitropoulos FA, Floudas CS, Kanakis MA, Vaiopoulos GA. Mitropoulos FA, et al. Thorac Cardiovasc Surg. 2009 Jun;57(4):187-90. doi: 10.1055/s-0029-1185302. Epub 2009 May 20. Thorac Cardiovasc Surg. 2009. PMID: 19670108 Review.
Sarcoidosis is a systemic disease which affects many organs, including the heart. Cardiac sarcoidosis has a reported incidence of about 25 % and carries a poor prognosis. ...We briefly review the current armamentarium for the diagnosis and treatment of cardiac …
Sarcoidosis is a systemic disease which affects many organs, including the heart. Cardiac sarcoidosis has a reported incidence …
Update in Cardiac Sarcoidosis.
Ribeiro Neto ML, Jellis CL, Joyce E, Callahan TD, Hachamovitch R, Culver DA. Ribeiro Neto ML, et al. Ann Am Thorac Soc. 2019 Nov;16(11):1341-1350. doi: 10.1513/AnnalsATS.201902-119CME. Ann Am Thorac Soc. 2019. PMID: 31322914 Review.
Once cardiac sarcoidosis is suspected, clinicians should be familiar with the prevalence of the disease in different clinical scenarios. ...Contemporary data suggest that long-term survival in cardiac sarcoidosis is better than previously believ …
Once cardiac sarcoidosis is suspected, clinicians should be familiar with the prevalence of the disease in different clinic …
Cardiac sarcoidosis.
Ayyala US, Nair AP, Padilla ML. Ayyala US, et al. Clin Chest Med. 2008 Sep;29(3):493-508, ix. doi: 10.1016/j.ccm.2008.03.005. Clin Chest Med. 2008. PMID: 18539240 Review.
Sarcoidosis is a systemic disease with a favorable prognosis, high remission rate, and low mortality. Cardiac involvement alters this prognosis. Clinical manifestations most commonly include arrhythmias, conduction abnormalities, and congestive heart failure. ...Risk strat …
Sarcoidosis is a systemic disease with a favorable prognosis, high remission rate, and low mortality. Cardiac involvement alters this progno …
341 results